Antiepileptic drug pregnancy registries: Do the latest findings concur?

Therapy

Volumn 7, Issue 5, 2010, Pages 517-526

  Tornes, Leticia ^a   Harden, Cynthia L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

antiepileptic drug; epilepsy; major congenital malformation; pregnancy; registry; seizure; teratogenicity; valproate; women with epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

AUSTRALIA; BIRTH CERTIFICATE; CANADA; CLINICAL TRIAL; CONGENITAL MALFORMATION; EPILEPSY; EPILEPTIC STATE; FETOTOXICITY; FINLAND; GESTATIONAL AGE; HEALTH CARE SYSTEM; HIGH RISK PREGNANCY; HUMAN; IRELAND; MONOTHERAPY; NEURAL TUBE DEFECT; NORTH AMERICA; POPULATION RESEARCH; PREGNANCY OUTCOME; REGISTER; REVIEW; RISK REDUCTION; SEIZURE; SWEDEN; TAIWAN; TERATOGENESIS; TERATOGENICITY; UNITED KINGDOM; UNITED STATES;

EID: 77957149537     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.2217/thy.10.54     Document Type: Review

References (22)

1. Meador KJ, Pennell PB, Harden CL et al.: Pregnancy registries in epilepsy: a consensus statement in health outcomes. Neurology 71(14), 1109-1117 (2008).
2. Tomson T, Battino D, French J et al.: Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries. Epilepsy Behav. 11(3), 277-282 (2007).
3. Tomson T, Battino D, Craig J et al.: Pregnancy registries: differences, similarities, and possible harmonization. Epilepsia 51(5), 909-915 (2010).
4. Vajda FJE, Hitchcock A, Graham J, OBrien T, Lander C, Eadie M: Seizure control in antiepileptic drug-treated pregnancy. Epilepsia 49(1), 172-175 (2008).
5. The EURAP Study Group: Seizure control and treatment in pregnancy: observations from the EURAP pregnancy registry. Neurology 66(3), 354-360 (2006).
6. Holmes LB, Harvey EA, Coull BA et al.: The teratogenicity of anticonvulsant drugs. N. Eng. J. Med. 344(15), 1132-1138 (2001).
7. Vajda FJE, Hitchcock A, Graham J et al.: Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur. J. Neurol. 13(6), 645-654 (2006).
8. Morrow J, Russell A, Guthrie E et al.: Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatr. 77(2), 193-198 (2006).
9. Meador KJ, Baker GA, Browning N et al.; NEAD Study Group: Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N. Engl. J. Med. 360(16), 1597-1605 (2009).
10. Wyszynski DF, Nambiasan M, Surve T, Alsdorf RM, Smith CR, Holmes LB: Increased rate of major malformation in offspring exposed to valproate during pregnancy. Neurology (64), 961-965 (2005).
11. Artama M, Auvinen A, Raudaskoski T, Isojarvi I, Isojarvi J: Antiepileptic drug use in women with epilepsy and congenital malformations in offspring. Neurology 64(6), 1874-1878 (2005).
12. Wide K, Winbladh B, Kallen B: Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation wide, population-based register study. Acta. Paediatr. 93(2), 174-176 (2004).
13. Holmes LB, Baldwin EJ, Smith CR et al.: Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 70(22), 2152-2158 (2008).
14. Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT; EUROCAT Antiepileptic Drug Working Group: Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations. Neurology 71(10), 714-722 (2008).
15. Holme LB, Wyszynski DF, Lieberman E: The AED (antiepileptic drug) pregnancy registry - A 6-year experience. Arch. Neurol. 61(5), 673-678 (2004).
16. Hunt S, Russell A, Smithson WH et al.: Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregancy Register. Neurology 71(4), 272-276 (2008).
17. Hunt S, Craig J, Russell A et al.: Levetiracetam in pregnancy: preliminary experience from UK epilepsy and pregnancy register. Neurology 67, 1876-1879 (2006).
18. Hibbard E, Smithells R: Folic acid metabolism and human embryopathy. Lancet 285(7398), 1254 (1965).
19. Czeizel AE: Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Res. A Clin. Mol. Teratol. 85(4), 260-268 (2009).
20. Morrow JI, Hunt SJ, Russell AJ: Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 80(5), 506-511 (2009).
21. Chen YH, Chiou HY, Lin HC, Lin HL: Affect of seizures during gestation on pregnant outcomes in women with epilepsy. Arch. Neurol. 66(8), 979-984 (2009).
22. GlaxoSmithKline Pregnancy Registries http://pregnancyregistry.gsk.com